CDC6 and cancer: We observed that BRCA1/2 gene alterations were mutually exclusive with amplification of all the oncogenes examined in the breast (CCND1, CCNE1 and CDC6) and ovarian (CCND1, CCNE1 and BRAF) cancer cohorts (Supplementary Fig. 1a, b).